Keriette

Ethinylestradiol and Levonorgestrel, the active ingredients in Keriette, are a combined oral contraceptive presented as a tablet for oral use. It treats contraception and helps regulate menstrual cycles in women of reproductive age.

GNH USA supplies Keriette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Keriette is a combined hormonal contraceptive used to prevent pregnancy and manage menstrual cycle disorders. - Contraception: provides reliable prevention of pregnancy when taken as prescribed. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Menstrual irregularities: reduces heavy or prolonged bleeding and improves cycle regularity.

Keriette may cause a range of adverse reactions. Common side effects are usually mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often improves with continued use. - Breast tenderness: temporary swelling or discomfort of the breasts. - Headache: mild to moderate intensity, may respond to simple analgesics. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in the legs, requiring immediate medical attention. - Pulmonary embolism: clot migration to the lungs, a life‑threatening emergency. - Stroke or myocardial infarction: rare cardiovascular events, especially in high‑risk individuals. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Liver dysfunction: jaundice or abnormal liver enzymes. - Vision changes: sudden loss of vision or visual disturbances.

Before prescribing Keriette, clinicians should evaluate individual risk factors and counsel patients on safe use. - Thromboembolic risk assessment: avoid in women with history of clotting disorders. - Cardiovascular evaluation: caution in smokers over 35 or those with hypertension. - Liver disease monitoring: use with care in patients with hepatic impairment. - Breast cancer history: consider alternative contraception for survivors. - Pregnancy testing: ensure patient is not pregnant before initiation. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and heat.

Keriette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): markedly reduce contraceptive effectiveness. - Rifampin or rifabutin: potent inducers that may lead to contraceptive failure. - St. John’s wort: herbal supplement that can decrease hormone levels.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly reduce contraceptive reliability. - Antifungal agents (e.g., fluconazole, itraconazole): can increase hormone concentrations. - Antiretroviral drugs (e.g., protease inhibitors): may alter hormone metabolism, requiring additional contraceptive measures.